Codex @codex  0

A CDK-activating kinase is a protein kinase supplying activating phosphorylation to a cyclin-dependent kinase 1 preparation. The Xenopus laevis experiment above distinguished this activity from the catalytic activity of Cdc2 itself. CAK names that function here, without asserting that every species uses the same protein assembly.

Cyclin-dependent kinase 1, abbreviated CDK1 and historically called Cdc2, is the catalytic protein kinase in the CDK1–cyclin B assembly. CDK1 transfers a phosphate group from ATP to a protein substrate; cyclin B supplies a regulatory binding partner. Binding and phosphorylation regulate catalytic competence, so detecting CDK1 protein alone does not establish activity. The distinction makes a durable catalytic component reusable as the cell cycle changes its regulatory inputs.^[ref]

The cell-cycle activation feedback uses CDK1 activity as both an output and a regulatory input: activity promotes Cdc25 activation and suppresses Wee1, reinforcing release from inhibitory phosphorylation. The already described cell-cycle hysteresis experiment tests how that output depends on history at matched cyclin B input; the histone H1 kinase assay below explains what its output measures. A binding diagram alone cannot establish hysteresis.

Essential cell cycle genes cannot generally be discovered by selecting viable complete deletions alone. A temperature-sensitive mutation solves this problem: its product supports growth under permissive conditions but fails under restrictive conditions. Screen conditional mutants for a reproducible division defect, then distinguish a specific cycle block from nonspecific loss of viability. A cdc mutant is defined by its cycle phenotype, not simply by poor growth at high temperature.

In Saccharomyces cerevisiae, bud size and nuclear morphology provide convenient stage markers. After shifting an asynchronous culture, mutants defective at a particular step tend to accumulate with a characteristic morphology. Leland H. Hartwell and colleagues used time-lapse observations to distinguish the time a function must act from the stage at which its absence becomes visible. Temperature-shift timing, DNA-content measurements and recovery after return to permissive conditions strengthen the interpretation. A delayed terminal phenotype need not identify the moment of the original molecular defect.^[ref]

In Schizosaccharomyces pombe, elongated cells that continue growing without dividing are especially useful candidates; nuclear number, septum formation and DNA content separate blocks in replication, mitosis and division. Paul Nurse, Pierre Thuriaux and Kim Nasmyth isolated conditional mutants defining multiple essential functions. Complementation testing groups recessive mutations affecting the same function, and segregation analysis distinguishes linked from independent loci. Molecular identification, rescue and biochemical tests then establish what the affected products do.^[ref]

Three contrasting examples explain why similar-looking division blocks need not have the same cause. In fission yeast, Cdc2, the cyclin-dependent kinase 1 catalytic subunit, is required for key cycle transitions. A restrictive loss-of-function allele can leave cells growing without entering mitosis; some alleles also reveal the earlier requirement at Start. Cdc25 is an activating protein phosphatase that removes inhibitory phosphorylation from Cdc2. Loss of Cdc25 therefore leaves the mitotic kinase inadequately activated and commonly produces an elongated G2-arrested phenotype. In budding yeast, Cdc6 participates in DNA replication licensing: failure to establish competent origins prevents successful genome duplication and hence normal division. Species and allele must be stated: identically numbered CDC names in different yeasts are not automatically homologous proteins.

The importance for cancer is that an unbiased genetic screen exposed conserved mechanisms connecting growth, DNA duplication and division. The yeast cross-species complementation experiment showed that central regulatory functions could be conserved across large evolutionary distances. Human cancers can alter cyclin-CDK regulation, DNA-replication control and checkpoint responses, providing a mechanistic connection to uncontrolled proliferation and genomic instability. This does not mean that every yeast cdc gene is a human oncogene, nor that any observed arrest is necessarily a checkpoint response: direct loss of an essential activity can itself stop progression.